Product Description

Ninlib 150mg Capsule is a prescription medication manufactured by Hetero Healthcare Limited and used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML), particularly in patients who are intolerant or resistant to previous therapies. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by targeting and blocking the BCR-ABL protein that promotes uncontrolled cell growth in CML. This medicine is commonly prescribed by oncologists due to its clinical effectiveness, targeted mechanism, and manageable safety profile. It may be used alone or in combination depending on your doctor's clinical judgement. Ninlib 150mg is produced under strict quality standards and used in both hospital and homecare settings. At Macarius Health, we ensure reliable access to high-value cancer treatments like Ninlib at affordable rates with assured cold-chain handling where necessary.